Connect Biopharma Holdings (CNTB) Other financing activities (2024 - 2026)

Connect Biopharma Holdings (CNTB) has reported Other financing activities for 3 consecutive years, with $18.6 million the latest figure, recorded in Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $18.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 9938.66% YoY) and the FY2025 annual result came in at $875000.0, up 351.03% from the prior year.
• Other financing activities improved to $18.6 million in Q1 2026 per CNTB's latest filing, from $640000.0 in the prior quarter.
• Over the last five years, Other financing activities for CNTB reached as high as $18.6 million in Q1 2026 and fell as low as $92000.0 in Q3 2025.
• A 3-year average of $3.3 million and a median of $122000.0 in 2024 frame the typical range for Other financing activities.
• The largest YoY upside for Other financing activities was 588.17% in 2025 against a maximum downside of 41.58% in 2025.
• Year by year, Other financing activities stood at $93000.0 in 2024, then jumped by 588.17% to $640000.0 in 2025, then jumped by 2806.25% to $18.6 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $18.6 million, $640000.0, and $92000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.